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Abstract
Background: Mu opioid receptor (MOR), which plays key roles in analgesia and also has effects on learning and
memory, was reported to distribute abundantly in the patches of the neostriatum. The marginal division (MrD) of
the neostriatum, which located at the caudomedial border of the neostriatum, was found to stain for enkephalin
and substance P immunoreactivities and this region was found to be involved in learning and memory in our
previous study. However, whether MOR also exists in the MrD has not yet been determined.
Methods: In this study, we used western blot analysis and immunoperoxidase histochemical methods with
glucose oxidase-DAB-nickel staining to investigate the expression of MOR in the MrD by comparison to the
patches in the neostriatum.
Results: The results from western blot analyses revealed that the antibody to MOR detected a 53 kDa protein
band, which corresponded directly to the molecular weight of MOR. Immunohistochemical results showed that
punctate MOR-immunoreacted fibers were observed in the “patch” areas in the rostrodorsal part of the neostriatum
but these previous studies showed neither labelled neuronal cell bodies, nor were they shown in the caudal part
of the neostriatum. Dorsoventrally oriented dark MOR-immunoreactive nerve fibers with individual labelled fusiform
cell bodies were firstly observed in the band at the caudomedial border, the MrD, of the neostriatum. The location
of the MOR-immunoreactivity was in the caudomedial border of the neostriatum. The morphology of the labelled
fusiform neuronal somatas and the dorsoventrally oriented MOR-immunoreacted fibers in the MrD was distinct
from the punctate MOR-immunoreactive diffuse mosaic-patterned patches in the neostriatum.
Conclusions: The results indicated that MOR was expressed in the MrD as well as in patches in the neostriatum of
the rat brain, but with different morphological characteristics. The punctate MOR-immunoreactive and diffuse
mosaic-patterned patches were located in the rostrodorsal part of the neostriatum. By contrast, in the MrD, the
dorsoventrally parallel oriented MOR-immunoreactive fibers with individual labelled fusiform neuronal somatas
were densely packed in the caudomedial border of the neostriatum. The morphological difference in MOR
immunoreactivity between the MrD and the patches indicated potential functional differences between them. The
MOR most likely plays a role in learning and memory associated functions of the MrD.
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The neostriatum in the rat brain has been reported to
be divided into two compartments, striosomes/patches
and matrix, which contribute to the heterogeneous nat-
ure of the neostriatum [1-3]. Pert et al [4] distinguished
the “patch” compartment by its dense concentration of
opioid receptors in the rat and termed the rest of the
surrounding striatal tissue “matrix”. The patch-matrix
compartment can be recognized on the basis of the
expression of several markers, including enkephalin,
substance P, calcium-binding protein and opioid recep-
tors. The matrix is enriched in met-enkephalin positive
cells [2,5] and acetylcholinesterase expressing cells [3,6].
In contrast, the striosomes/patch compartment is
enriched in fibers that are immunoreactive for substance
P and leu-enkephalin [7] and calretinin [8].
The marginal division of the neostriatum (MrD) was
shown to be located at the caudomedial border of the
neostriatum, surrounding the rostrolateral edge of the glo-
bus pallidus in the rat brain [9]. The localization of the
MrD has been confirmed by other researchers. Schoen
and Graybiel found 5’-nucleotidase activity densely
expressed in the developing rodent caudoputamen (loca-
tion of the MrD) association of with dopamine islands and
striosomes in rat, but with extrastriosomal matrix in
mouse [10]. The staining intensity for the A subtype of
a2-adrenergic receptors was higher in the MrD than in
the rest of the rat striatum [11]. Most of the neuropeptides
and receptors expressed in the MrD were reported to
exert influences on learning and memory functions of the
brain [12,13]. The MrD has been found to be involved in
learning and memory through behavioural studies of rats
[14], LTP studies [15] and in functional magnetic reso-
nance image studies of humans [16]. In addition, the MrD
was implicated in the modulation of pain by other investi-
gators. Nociceptive neurons were reported to be localized
exclusively in the MrD of rat striatum by Chudler and
Dong [17] and Chudler et al. [18], using neurophysiologi-
cal methods, suggesting that the MrD might be involved
in pain modulation. The MrD is distinguished from the
rest of the neostriatum by its special cytoarchitecture, its
neurochemistry, and the efferent connections to the glo-
bus pallidus and substantia nigra. Previous immunohisto-
chemical studies on the MrD showed a unique
immunohistochemical staining profile by comparison to
the rest of the neostriatum. Like the patches, the staining
of AChE was weaker in the MrD than in the rest of the
neostriatum [9], and a layer of densely packed substance P
and leu-enkephalin immunoreactive fibers and terminals
was observed in the MrD in rat and cat [19]. However,
met-enkephalin immunostaining was reported to be more
intensely packed in the rat MrD than in the rest of the
neostriatum, which differed from that of the patches but
was similar to that of matrix [9].
Mu opioid receptors (MORs) are one member of the
seven transmembrane family of G-protein coupled
receptors [20-23]. Their activation, by endogenous
opioid peptides and exogenous opioid drugs, is inti-
mately involved with a range of physiological processes
underlying pain and analgesia, tolerance and depen-
dence, learning and memory, eating and drinking, alco-
hol, drugs of abuse etc [24]. The distribution of MOR
has been extensively studied in the rat striatum through
the techniques of binding autoradiography [25-27], in
situ hybridization histochemistry [20-23,28-31] and
immunohistochemistry [32-37]. These studies have indi-
cated that MOR is preferentially localized to the patches
of the rat neostriatum. The “patch” compartment is dis-
tinguished from the matrix by its dense concentration of
MOR in the rat neostriatum, and the restricted MOR
binding pattern is considered one of the striatal markers.
However, the distribution of MOR has not yet been
described in the MrD. In this study, we employed wes-
tern blot analysis and immunoperoxidase histochemical
methods with glucose oxidase-DAB-nickel staining to
investigate whether MORs also localize to the MrD, and
we compared the immunohistochemical distribution of
MOR-immunoreactivity in the MrD with that of patches
of the neostriatum.
Methods
Animals
Experiment were performed on 10 adult male Sprague-
Dawley rats (220 g–250 g, Laboratory animal center,
Guangzhou University of Chinese Medicine, China)
maintained on a 12/12 hours light/dark cycle and were
allowed free access to food and water. Experiments were
carried out according to a protocol approved by the
Animal Care Committee at South China Normal Uni-
versity and in accordance with policies and guidelines of
the Chinese Council on Animal Care.
Antibody
A rabbit polyclonal antiserum raised against a synthetic
peptide (aa 384-398) corresponding to the C-terminus
of rat MOR1 (Immunostar, Cat. 24216) was used in this
study. This commercially available antibody has been
extensively used for immunohistochemistry in the rat
CNS [32,38-44]. Specificity of the MOR antiserum has
been demonstrated previously on the basis of epitope-
expressing cell lines, western blotting, and adsorption
controls [32,45].
Western blot
Tissues (the MrD, the hippocampus of rat brains) were
minced and homogenized in cold lysis buffer (50 mM
Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 1%
sodium deoxycholate, 0.1% SDS, and protease inhibitors
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BCA method. Protein samples (40-50 μg) were subjected
to SDS-PAGE and transferred onto a PVDF membrane
according to the method of Towbin et al [46]. The
membrane was blocked with 5% non-fat dry milk in
Tris-buffered saline (TBS) for 1 hr, and then incubated
with anti-MOR (1:1500 dilution) antibody in TBS con-
taining 0.1% Tween-20 at 4°C overnight. After washing
with TBST (20 mM Tris, 140 mM NaCl, 0.1% Tween-
20, pH 7.6), immunoreactive bands were detected with
goat anti-rabbit IgG conjugated with horseradish peroxi-
dase (1:800) and developed using the ECL detection sys-
tem. The hippocampus was used as the positive control
group.
Immunohistochemistry
Rats were heavily anesthetized with chloral hydrate (400
mg/kg, i.p.), and perfused through the aortic arch with
200 ml 0.9% saline, followed by 500 ml 4% paraformal-
dehyde in 0.1M phosphate buffer (PB, pH 7.4) in 20-30
minutes. The brain was removed and post-fixed for 2
hours at 4°C in 4% paraformaldehyde in 0.1M PB, pH
7.4. The brain was then transferred to 30% sucrose in
0.1M PB and stored at 4°C until the tissue had sunk to
the bottom of the sucrose solution in the bottle. Tissues
were cropped, embedded in Jung Tissue Freezing Med-
ium (Leica, Germany) and gradually frozen at -18°C in a
Leica CM 1950 cryostat. Brains were sectioned coronally
of 30-μm thickness at -18°C in a Leica CM 1950 cryo-
stat and collected in 0.1M PB, pH 7.4.
Tissues were processed as floating sections. Sections
were washed with 0.01M phosphate buffered-saline
(PBS, pH 7.4) and incubated in the primary antibody
against Mu opioid receptor (1:3500; Rabbit anti-MOR,
Immunostar, Cat. 24216) diluted in PBS/0.3% Triton X-
100 for 18 hours at 4°C. Unbound primary antibodies
were then removed by washing with PBS (pH 7.4) three
times. Sections were processed with Rabbit HRP-Poly-
mer Kit (PV-6001, ZSGB-BIO, China) and further trea-
ted by the glucose oxidase-DAB-nickel method [47].
The reaction was terminated by three consecutive 0.1M
acetate buffer (pH 6.0) washes, after which sections
were mounted on gelatin-coated slides. The sections
were then treated with graded alcohols, and xylene,
placed on coverslips with Neutral balsam, and observed
with a Lecia microscope (DM 2500, Germany). In the
control experiment, the primary antibody was replaced
with 0.3% Triton X-100 in PBS (pH 7.4).
Results
Western blot
Western blot analyses were performed on lysates of the
rat MrD and also on the Hippocampal tissue using a
polyclonal antiserum against a peptide mapping at the C
terminus of MOR. The results revealed an immunoreac-
tive band of about 53 kDa (Figure 1 line1) that corre-
sponds to the de-glycosylated form of MOR [48]. In the
positive control group, the positive signal of the specific
53 kDa immunoreactive band was also obtained (Figure
1 line2).
Overview of the immunohistochemical localization of mu
opioid receptor
MOR-immunoreactivity was found unevenly distributing
at different levels of the neostriatum. The neuropil
labelled with intense MOR immunoreactivity was seen in
a dorsoventrally oriented moon-shaped band in the MrD
at the caudomedial border of the neostriatum. The
mosaic distribution patterns of MOR staining were
observed in patches in the rostrodorsal part of the neos-
triatum. Details of the distribution of MORs in the MrD
and the patches of the neostriatum were presented below.
Immunohistochemical localization of mu opioid receptor
in the Neostriatum (excluding the MrD)
The typical mosaic pattern of distribution of MOR
immunoreactivity was observed in the neostriatum (St).
Dense MOR immunoreactivity was seen in the patches
in the rostrodorsal portion of the neostriatum (arrows
in Figure 2A, B) and in the subcallosal streak (arrow-
heads in Figure 2A, B) that surrounds the outside edge
of the neostriatum as well. The immunoreactivity varied
at different levels of the neostriatum. This labelling was
m o s tp r o m i n e n ta tt h er o s t r a lp o r t i o na n di tw a sm o r e
pronounced rostral-laterally than caudal-medially. At
the rostral portion (Figure 2A), abundant patches were
distributed irregularly, exhibiting complex and tortuous
morphology with multiple extensions. While the patches
at the medial portion (Figure 2B) were sparse, small in
size and dorsoventrally oriented. No patches were seen
in the caudal part of the neostriatum where the MOR
immunoreactivity was densely accumulated in the MrD
(Figure 2C). At higher magnification fine, diffuse, punc-
tate MOR immunoreactivity was seen within the patches
(Figure 3D). The punctate staining of neuronal cell
bodies was not observed in the neostriatum.
53 kDa
1         2
Figure 1 Immunoblot of SDS extracts of the Marginal division
(MrD) and the hippocampus of the rat brain with an anti-
peptide antibody. Lane 1, the MrD; Lane 2, hippocampus (positive
control).
Wang et al. Journal of Biomedical Science 2011, 18:34
http://www.jbiomedsci.com/content/18/1/34
Page 3 of 9Immunohistochemical localization of mu opioid receptor
in the marginal division of the neostriatum (MrD)
MOR immunoreactivity was concentrated in the dorso-
ventrally oriented, moon-shaped band that corresponded
to the MrD at low magnification of the microscope (Fig-
ure 2B, C; Figure 3A; Figure 4A). At higher magnifica-
tion, dorsoventrally oriented positive MOR
immunoreactive dendrites and axons were seen within
the MrD (Figure 3B), and a positive MOR-immunos-
tained fusiform cell body was also observed among the
labelled nerve fibers (the arrow in Figure 3C).
Dense dorsoventral parallel-oriented MOR-immunos-
tained nerve fibers and terminals were seen concen-
trated in the MrD at the caudomedial portion of the
neostriatum (Figure 2C; Figure 4A). Individual MOR-
immunostained fusiform cell bodies were also observed
in dorsoventral MOR-immunoreactive nerve fibers that
were parallel in their distribution (arrows in Figure 4B,
C).
Discussion
Morphological characteristics of the MrD in the
neostriatum of the rat brain
The MrD is a pan-shaped region within the neostria-
tum. It localizes at the caudomedial edge of the neos-
triatum, surrounding the rostrolateral border of the
globus pallidus (GP), in the brain of rats (Figure 5A).
The MrD can be characterized from the criteria of the
rat atlas [49], as well as from its special neuronal mor-
phology (Figure 5B, C), its immunohistochemical char-
acteristics and by the analysis of its specific projection
patterns [9].
The rostral part of the MrD appears simultaneously
with the appearance of the GP and lies between the cau-
domedial portion of neostriatum (St) and the rostrolat-
eral border of GP in coronal sections of rat brain. The
central part of the MrD is located between the St and
GP, leaving the caudal part medial to the caudal-most
edge of St where the GP gradually disappears. Morpho-
logically, the neuronal somatas of the marginal division
are mostly fusiform in shape, with their long axes run-
ning parallel to the border between the striatum and the
globus pallidus. Immunohistochemically, the marginal
division is lighter in AChE staining without choline
acetyltransferase (ChAT)-immunoreacted neurons. It
was more intensely stained for substance P and Met-
enkephalin-immunoreactive fibers and terminals than
the rest of the neostriatum. The efferent fibers of MrD
project to the caudal-most part of GP which contains
cholinergic neurons of nucleus basalis of Meynert [9,50].
It was demonstrated that the pedunculopontine nucleus
gives rise to massive afferent terminals in the MrD,
which were seldom found in the rest of the striatum in
squirrel monkey [51]. Shammah-Lagnado et al [52]
IC
St
C
MrD
A
B
GP
St
MrD
Figure 2 Comparative distribution of MOR-immunoreactivity at
different levels of coronal sections of the rat neostriatum (St):
coronal sections stained with anti-MOR and GDN method
arranged in a rostrocaudal order. A: MOR-immunoreactivity was
localized in densely stained patches (arrows) and the subcallosal
streak (arrowheads) at the rostral part of the St. Patches of MOR-
immunoreactivity was most prominent in the rostral, dorsal portion
of the neostriatum, which distributed irregularly, exhibiting complex
and tortuous fields with multiple extensions. B: At the rostromedial
portion of the St, the number of the patches decreased and the
staining of MOR-immunoreactivity in the MrD was seen in a moon
shape band that parallels with the subcallosal streak. C: At the
caudomedial portion of the St, MOR-immunoreactivity was seen
densely stained in the band of nerve fibers that arranged in parallels
in the MrD. All scale bars: 500 um.
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the posterior limb of the anterior commissure in the rat
through the use of retrograde (cholera toxin B subunit)
tracers. Retrogradely labelled cells are present ipsilater-
ally in the MrD. This finding indicated that the MrD
connected to the interstitial nucleus of the posterior
limb of the anterior commissure.
In the present study, the position of the MrD was iden-
tified according to its location in the rat atlas, and con-
firmed by the morphology of individual MOR-
immunoreactive fusiform neuronal somatas and the
dorsoventral parallel-orientated nerve fibers that were
numerous at the caudomedial margin of the neostriatum.
Existence of MOR in the MrD
In this study, the presence of MOR was firstly described
in the MrD by western blot analysis and immunohisto-
chemical methods. Enkephalin, which has a high affinity
to MOR and is considered to be one of the endogenous
ligands for MOR, was reported to be expressed mostly
on the fibers and few on neuronal somatas of the MrD
[53]. Electron microscopic analysis of the MrD in the
St
GP
C
B
St
GP
St
St
D
d
St
GP
MrD
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b
Figure 3 Localization of MOR-immunoreactivity in medial part of the neostriatum (St) in coronal sections of the rat brain stained with
anti-MOR and GDN method. A: Figure at low magnification illustrating the distribution of MOR-immunoreactivity in rostral part of MrD and the
St. MOR-immunoreactivity labelled nerve fibers were densely packed in a moon-like nerve fiber “band” dorsoventrally oriented in the MrD
between the St and the GP (arrow indicated by b in A). Patches of MOR-immunoreactivity were localized in the St. B: At higher magnification,
fine, punctate MOR-immunoreactivity was seen within the nerve fibers of the “band”. C: The fusiform cell body and its processes were also
observed among the diffuse, punctate staining in parallel-arranged nerve fibers in the band of the MrD (arrow in C). Several patches of MOR-
immunoreactivity were localized in the St, with their extensions dorsoventrally oriented (the arrow indicated by d in A; D). Arrows of b and d
refer to areas shown at higher magnification in B and D, Scale bars: A, 500 um; B, C and D, 50 um.
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tivity was mainly on axons, and these axons formed
complex synapses on unlabeled dendrites or axons
(Unpublished results). In the present study, MOR
immunoreactivity was mostly observed in dorsoventrally
oriented nerve fibers and terminals in the MrD. This
means that there are most likely interactions between
the ENK-immunoreactive nerve fiber terminals and
MOR in the MrD. In addition, this distribution of noci-
ceptive neurons was proved in the MrD using a
St
A
MrD
IC
C B
Figure 4 Photographs of coronal sections of the caudal part of the neostriatum (St) illustrating the presence of MOR in the MrD.N o
obvious “patches” of MOR-immunoreactivity was seen. A: A figure at low magnification showed dense accumulation of nerve fibers of MOR-
immunoreactivity in the MrD and in the globus pallidus (GP) as well, and weak staining in the rest of the St. B: At higher magnification, the
fusiform cell bodies exhibited MOR-immunoreactivity in puncta within parallel-arranged nerve fibers in the MrD (the arrow in B). C: The cell
bodies and their dendrites stretched dorsoventrally were showed in the MrD (arrows in C). Scale bars: A, 200 um; B, C, 50 um.
B
C
A
Figure 5 The location and cellular morphology of the marginal division (MrD). A: The MrD is at the caudomedial edge of the neostriatum
(St) and surrounding the rostrolateral of the globus pallidus (GP). B: More than 90% neurons in the striatum are medium-sized, round or
multipolar neuronal cells with many long dendrites radiating from the neuronal cell bodies. C: The neuronal somata in the MrD are fusiform in
shape with their long axes running parallel to the border between the St and the GP.
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MOR plays key roles in analgesia and also has effects on
learning and memory. The presence of both enkephalin
a n dM O Ri nt h eM r Ds u g g e s t st h a tM O Rm i g h tp l a ya
role in the learning and memory functions of the MrD
and probably in the pain modulation process. However,
definitive evidence for this idea is beyond the scope of
this study and will await further experimentation.
Comparison of MOR-immunoreactivity in the MrD and the
neostriatum
Although the distribution of MOR in the striatum has
been extensively studied previously, the presence of
MOR in the MrD has not been previously examined. In
this study, high level MOR immunoreactivity was
detected in patches of the neostriatum but with no
expression in matrix, as described in some previous pub-
lished papers [32-37]. We firstly observed strongly
labelled MOR-immunoreacted fibers, terminals and indi-
vidual fusiform neuronal somatas in the dorsoventrally
oriented band at caudomedial edge of the neostriatum,
which was the location of the MrD. Immunohistochem-
ical features of MOR immunoreactivity in the MrD are
different from those of patches in the neostriatum (Table
1). Firstly, the localization of MOR-immunoreactivity in
patches and the MrD is different. Positive MOR immu-
noreactivity are seen in the patches in the rostrodorsal
part of the neostriatum, while MOR-immunoreactive
fibers, terminals and neurons are observed in the MrD at
the caudomedial edge of the neostriatum. Secondly, the
morphology of the individual labelled neuronal somata in
the MrD is fusiform shaped, whereas the labelled neuro-
nal somata are not seen in patches of the neostriatum.
Thirdly, the densely packed MOR-immunoreacted nerve
fibers are dorsoventral and oriented in parallel in the
MrD, but MOR-immunoreactive nerve fibers are irregu-
larly distributed in mosaic patterns to make the patches
in the rostrodorsal part of the neostriatum.
MOR is preferentially localized in patches in the rat
neostriatum. Although MOR-immunoreactive areas
highly enriched in patches are of interest, but they are
not easy to be stereotaxically localized. Manipulation
aims to reach patch or matrix compartment are difficult
in vivo. The MrD could be stereotaxically identified in
vivo from the Atlas of the rat brain. Our data indicate
that the MrD is an ideal choice for the study of MOR in
the neostriatum in vivo.
Conclusions
We have for the first time demonstrated the existence of
mu opioid receptors (MORs) in the marginal division of
the neostriatum by western blot analysis and immuno-
histochemical methods. The unique morphology of the
labelled fusiform neuronal somatas and the dorsoven-
trally oriented MOR-immunoreactive fibers in the MrD
at the caudomedial margin may serve as the markers to
distinguish it from patches in the neostriatum. The
MOR has been reported to be involved in pain modula-
tion and learning and memory. The pain related neu-
rons have been detected exclusively in the marginal
division of the neostriatum. Therefore, MOR is likely to
play a role in learning and memory functions of the
MrD as well as in pain modulation. The MrD constitu-
tes an ideal region for the study of MOR in the neos-
triatum, because of its high density of MOR and its
consistent reproducible localization in the brain of rat.
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